TORONTO, April 27, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its Vice President of Finance and Chief Financial Officer, Shameze Rampertab, will present a Company overview at the Taglich Brothers 8th Annual Small Cap Equity Conference in New York City at 9:30 a.m. ET on May 3, 2011.
